Results 301 to 310 of about 225,115 (385)

Landscape and Climate‐Associated Selection in the Native and Widespread Bumblebee, Bombus terrestris

open access: yesMolecular Ecology, EarlyView.
ABSTRACT Anthropogenic land‐use and climate change pose novel selection pressures on bees, yet their evolutionary responses in terms of morphological or physiological adaptations remain unclear. While adaptive responses are expected, these may be constrained by gene flow when changes in selection pressures are spatially heterogeneous.
Cecilia Kardum Hjort   +4 more
wiley   +1 more source

A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's disease. [PDF]

open access: yesJ Prev Alzheimers Dis
Greeley D   +11 more
europepmc   +1 more source

Entomopathogenic Nematodes Induce Metabolic Reallocation in Maize Roots Without Altering the Performance of Two Root Herbivores, Diabrotica virgifera and Diabrotica balteata

open access: yesPlant, Cell &Environment, EarlyView.
ABSTRACT Entomopathogenic nematodes (EPNs) are key biological control agents in agriculture, but their direct effects on plant metabolism and resistance to herbivory remain underexplored. By combining transcriptomic, metabolomic, and herbivore assays, this study aimed at providing a holistic description of maize root responses to EPNs and to assess ...
Arletys M. Verdecia‐Mogena   +7 more
wiley   +1 more source

Effects of Roflumilast on Exacerbations and Lung Function in COPD Patients with Bronchiectasis. [PDF]

open access: yesChonnam Med J
Lee JK   +7 more
europepmc   +1 more source

Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis in Children Aged 2–11 Years

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Two 4‐week, phase 2, open‐label, maximal usage pharmacokinetic (PK) and safety studies of once‐daily roflumilast cream 0.3% (a potent phosphodiesterase 4 inhibitor) were conducted in children aged 2–5 years and 6–11 years with psoriasis. Evidence of systemic exposure to roflumilast and its active N‐oxide metabolite was seen in most patients ...
Adelaide A. Hebert   +13 more
wiley   +1 more source

Effects of soluble guanylyl cyclase stimulation on muscle oxygenation and exercise capacity in heart failure with mildly reduced ejection fraction

open access: yesExperimental Physiology, EarlyView.
Abstract Heart failure (HF) with a mildly reduced ejection fraction (HFmrEF; 40%–49%) is present in ≤25% of HF patients. Therapeutic treatment options for HFmrEF‐associated exercise intolerance are limited. Nitric oxide (NO)‐independent stimulation of soluble guanylyl cyclase to improve peripheral vasodilatation offers a novel approach to enhance ...
Ramona E. Weber   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy